≡

Cytochrome b5 Reductase 3 (CYB5R3)

[Edit]

DIA1; Diaphorase-1; NADH-cytochrome b5 reductase 3

Cytochrome b5 Reductase 3 (CYB5R3)
CCC S301
HGNC 2873
MGI 94893
PubMed 2479590
RGD 2502
UniProt P00387
Wiki CYB5R3
The CYB5R3 gene encodes cytochrome b5 reductase-3, an enzyme that catalyzes the transfer of reducing equivalents from NADH to cytochrome b5 (CYB5A), which then acts as an electron donor. The membrane-bound isoform of CYB5R3 plays a role in physiologic processes, including cholesterol biosynthesis and fatty acid elongation and desaturation, whereas the soluble isoform of CYB5R3 is present in erythrocytes and functions to reduce methemoglobin to hemoglobin. There are 2 forms of NADH-cytochrome b5 reductase: a membrane-bound form in somatic cells and a soluble form in erythrocytes. The former exists mainly on the cytoplasmic side of the endoplasmic reticulum and functions in desaturation and elongation of fatty acids, in cholesterol biosynthesis, and in drug metabolism.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Cytochrome b5 Reductase 3 (CYB5R3) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Cytochrome b5 Reductase 3 (CYB5R3) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cytochrome b5 Reductase 3 (CYB5R3) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cytochrome b5 Reductase 3 (CYB5R3) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cytochrome b5 Reductase 3 (CYB5R3) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Cytochrome b5 Reductase 3 (CYB5R3) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Cytochrome b5 Reductase 3 (CYB5R3) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cytochrome b5 Reductase 3 (CYB5R3) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cytochrome b5 Reductase 3 (CYB5R3) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cytochrome b5 Reductase 3 (CYB5R3) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Cytochrome b5 Reductase 3 (CYB5R3) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Cytochrome b5 Reductase 3 (CYB5R3) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cytochrome b5 Reductase 3 (CYB5R3) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cytochrome b5 Reductase 3 (CYB5R3) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cytochrome b5 Reductase 3 (CYB5R3) ELISA Kit Customized Service Offer
  1. "The organization and the complete nucleotide sequence of the human NADH-cytochrome b5 reductase gene."Gene 80:353-361(1989) [PubMed] [Europe PMC] [Abstract]
  2. "A genome annotation-driven approach to cloning the human ORFeome."Genome Biol. 5:R84.1-R84.11(2004) [PubMed] [Europe PMC] [Abstract]
  3. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  4. "The DNA sequence of human chromosome 22." Nature 402:489-495(1999) [PubMed] [Europe PMC] [Abstract]
  5. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  6. "Molecular cloning of cDNAs of human liver and placenta NADH-cytochrome b5 reductase."Proc. Natl. Acad. Sci. U.S.A. 84:3609-3613(1987) [PubMed] [Europe PMC] [Abstract]
  7. "The NH2-terminal structures of human and rat liver microsomal NADH-cytochrome b5 reductases."J. Biochem. 105:312-317(1989) [PubMed] [Europe PMC] [Abstract]
  8. "Complete amino acid sequence of NADH-cytochrome b5 reductase purified from human erythrocytes."J. Biochem. 99:407-422(1986) [PubMed] [Europe PMC] [Abstract]
  9. "Amino acid sequence of NADH-cytochrome b5 reductase of human erythrocytes."J. Biochem. 96:579-582(1984) [PubMed] [Europe PMC] [Abstract]
  10. "An erythroid-specific transcript generates the soluble form of NADH-cytochrome b5 reductase in humans."Blood 92:310-319(1998) [PubMed] [Europe PMC] [Abstract]
  11. "Role of cysteine residues in human NADH-cytochrome b5 reductase studied by site-directed mutagenesis. Cys-273 and Cys-283 are located close to the NADH-binding site but are not catalytically essential."J. Biol. Chem. 266:7531-7536(1991) [PubMed] [Europe PMC] [Abstract]
  12. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  13. "Lysine acetylation targets protein complexes and co-regulates major cellular functions."Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract]
  14. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  15. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  16. "Structure of human erythrocyte NADH-cytochrome b5 reductase."Acta Crystallogr. D 60:1929-1934(2004) [PubMed] [Europe PMC] [Abstract]
  17. "Structural role of serine 127 in the NADH-binding site of human NADH-cytochrome b5 reductase."J. Biol. Chem. 266:66-70(1991) [PubMed] [Europe PMC] [Abstract]
  18. "Exonic point mutations in NADH-cytochrome B5 reductase genes of homozygotes for hereditary methemoglobinemia, types I and III: putative mechanisms of tissue-dependent enzyme deficiency."Am. J. Hum. Genet. 48:799-808(1991) [PubMed] [Europe PMC] [Abstract]
  19. "Enzymatic instability of NADH-cytochrome b5 reductase as a cause of hereditary methemoglobinemia type I (red cell type)."J. Biol. Chem. 267:20416-20421(1992) [PubMed] [Europe PMC] [Abstract]
  20. "An in-frame deletion of codon 298 of the NADH-cytochrome b5 reductase gene results in hereditary methemoglobinemia type II (generalized type). A functional implication for the role of the COOH-terminal region of the enzyme."J. Biol. Chem. 269:5952-5957(1994) [PubMed] [Europe PMC] [Abstract]
  21. "Four new mutations in the NADH-cytochrome b5 reductase gene from patients with recessive congenital methemoglobinemia type II."Blood 85:2254-2262(1995) [PubMed] [Europe PMC] [Abstract]
  22. "A high-frequency polymorphism of NADH-cytochrome b5 reductase in African-Americans."Hum. Genet. 99:248-250(1997) [PubMed] [Europe PMC] [Abstract]
  23. "Identification of a novel point mutation (Leu72-to-Pro) in the NADH-cytochrome b5 reductase gene of a patient with hereditary methaemoglobinaemia type I."Br. J. Haematol. 102:575-577(1998) [PubMed] [Europe PMC] [Abstract]
  24. "Molecular basis of hereditary methaemoglobinaemia, types I and II: two novel mutations in the NADH-cytochrome b5 reductase gene."Br. J. Haematol. 103:922-930(1998) [PubMed] [Europe PMC] [Abstract]
  25. "A novel mutation in the NADH-cytochrome b5 reductase gene of a Chinese patient with recessive congenital methemoglobinemia."Blood 95:3250-3255(2000) [PubMed] [Europe PMC] [Abstract]
  26. "Arginine-glutamine replacement at residue 57 of NADH-cytochrome b5 reductase in Chinese hereditary methemoglobinemia."Zhonghua Xue Ye Xue Za Zhi 18:200-203(1997) [PubMed] [Europe PMC] [Abstract]
  27. "Familial idiopathic methemoglobinemia revisited: original cases reveal 2 novel mutations in NADH-cytochrome b5 reductase."Blood 100:3447-3449(2002) [PubMed] [Europe PMC] [Abstract]
  28. "Recessive congenital methaemoglobinaemia: functional characterization of the novel D239G mutation in the NADH-binding lobe of cytochrome b5 reductase."Br. J. Haematol. 129:847-853(2005) [PubMed] [Europe PMC] [Abstract]